Quick Answer
Concord Medical Services Holdings Ltd reported Diluted EPS of $2.35 per share (loss) for fiscal year 2024.
Concord Medical Services Holdings Ltd Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$2.35 | -3.5% |
| 2023 | -$2.27 | +39.3% |
| 2022 | -$3.74 | +40.3% |
| 2021 | -$6.26 | -22.5% |
| 2020 | -$5.11 | -155.5% |
| 2016 | -$2.00 | -244.8% |
| 2015 | -$0.58 | -163.0% |
| 2014 | $0.92 | +43.8% |
| 2013 | $0.64 | -32.6% |
| 2012 | $0.95 | — |
- Concord Medical Services Holdings Ltd showed a decrease of -3.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2024 period, Concord Medical Services Holdings Ltd’s diluted eps has declined by 347.4% (from $0.95 per share to $2.35 per share (loss)).
- The most recent figure is from Concord Medical Services Holdings Ltd’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 25, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: